Immuron (IMRN) Interest & Investment Income (2017 - 2024)
Immuron's (IMRN) quarterly Interest & Investment Income came in at $35.3 billion in Q4 2024, up 23001335.32% year-on-year from N/an in Q1 2024, and up 23001335.32% quarter-over-quarter from $153508.0 in Q4 2023.
Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends
Immuron's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $35.3 billion for Q4 2024.
- On a quarterly basis, Interest & Investment Income rose 23001335.32% year-over-year to $35.3 billion in Q4 2024; TTM through Dec 2024 was $35.3 billion, a 16998463.83% increase from a year earlier, with the FY2025 full-year figure at $88058.7, down 59.03% from the prior year.
- Interest & Investment Income grew to $35.3 billion in Q4 2024 per IMRN's latest filing, from $153508.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $35.3 billion in Q4 2024 and bottomed at $63.29 in Q4 2020.
- The 5-year median for Interest & Investment Income is $54072.0 (2022), against an average of $7.1 billion.
- Across the five-year window, Interest & Investment Income gained 19.66% in 2021 and jumped 23001335.32% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $63.29 in 2020, then gained by 19.66% to $75.73 in 2021, then jumped by 71296.7% to $54072.0 in 2022, then soared by 183.9% to $153508.0 in 2023, then soared by 23001335.32% to $35.3 billion in 2024.
- Per Business Quant, the three latest IMRN Interest & Investment Income figures stand at $35.3 billion (Q4 2024), $153508.0 (Q4 2023), and $54072.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35.31 Bn |
| Dec 31, 2023 | 153,508.00 |
| Dec 31, 2022 | 54,072.00 |
| Dec 31, 2021 | 75.73 |
| Dec 31, 2020 | 63.29 |
| Dec 31, 2019 | 2.59 |
| Dec 31, 2018 | 39.00 |
| Dec 31, 2017 | 33.51 |